#SUVEN LIFESCIENCES
Suven’s molecule SUVN-502 did not meet pre-specified primary endpoints in Phase 2 study 🙁
Was being studied for Alzheimer’s disease
If outcome would have been positive, it could have been an out licensing opportunity for co
Feedback
SUVEN 
Reputation: 62,732 • Dec 2, 2019 3:04 PM
Vote
Comment
Share
0 Comment
list
This list is empty..
Cheer up, all is well :)